Macrophages and neurodegeneration - PubMed (original) (raw)
Review
Macrophages and neurodegeneration
Jerome J A Hendriks et al. Brain Res Brain Res Rev. 2005 Apr.
Abstract
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS). Demyelination is a classical feature of MS lesions, and neurological deficits are often ascribed to the reduced signal conduction by demyelinated axons. However, recent studies emphasize that axonal loss is an important factor in MS pathogenesis and disease progression. Axonal loss is found in association with cellular infiltrates in MS lesions. In this review, we discuss the possible contribution of the innate immune system in this process. In particular, we describe how infiltrated macrophages may contribute to axonal loss in MS and in experimental autoimmune encephalomyelitis (EAE), the animal model for MS. An overview is given of the possible effects of mediators, which are produced by activated macrophages, such as such as pro-inflammatory cytokines, free radicals, glutamate and metalloproteases, on axonal integrity. We conclude that infiltrated macrophages, which are activated to produce pro-inflammatory mediators, may be interesting targets for therapeutic approaches aimed to prevent or reduce axonal loss during exacerbation of inflammation. Interference with the process of infiltration and migration of monocytes across the blood-brain barrier is one of the possibilities to reduce the damage by activated macrophages.
Similar articles
- Neurodegeneration in autoimmune CNS inflammation.
Herz J, Zipp F, Siffrin V. Herz J, et al. Exp Neurol. 2010 Sep;225(1):9-17. doi: 10.1016/j.expneurol.2009.11.019. Epub 2009 Dec 1. Exp Neurol. 2010. PMID: 19961850 Review. - Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
Lassmann H. Lassmann H. Exp Neurol. 2010 Sep;225(1):2-8. doi: 10.1016/j.expneurol.2009.10.009. Epub 2009 Oct 17. Exp Neurol. 2010. PMID: 19840788 Review. - Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F. Vogt J, et al. Ann Neurol. 2009 Sep;66(3):310-22. doi: 10.1002/ana.21719. Ann Neurol. 2009. PMID: 19798635 - Neuronal injury in chronic CNS inflammation.
Zindler E, Zipp F. Zindler E, et al. Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29. Best Pract Res Clin Anaesthesiol. 2010. PMID: 21619866 Review. - Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis.
Hendriks JJ, Alblas J, van der Pol SM, van Tol EA, Dijkstra CD, de Vries HE. Hendriks JJ, et al. J Exp Med. 2004 Dec 20;200(12):1667-72. doi: 10.1084/jem.20040819. J Exp Med. 2004. PMID: 15611292 Free PMC article.
Cited by
- Immune cell distribution and immunoglobulin levels change following sciatic nerve injury in a rat model.
Yuan W, Feng X. Yuan W, et al. Iran J Basic Med Sci. 2016 Jul;19(7):794-9. Iran J Basic Med Sci. 2016. PMID: 27635205 Free PMC article. - Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation.
van Horssen J, Singh S, van der Pol S, Kipp M, Lim JL, Peferoen L, Gerritsen W, Kooi EJ, Witte ME, Geurts JJ, de Vries HE, Peferoen-Baert R, van den Elsen PJ, van der Valk P, Amor S. van Horssen J, et al. J Neuroinflammation. 2012 Jul 2;9:156. doi: 10.1186/1742-2094-9-156. J Neuroinflammation. 2012. PMID: 22747960 Free PMC article. - Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis.
Michailidou I, Naessens DM, Hametner S, Guldenaar W, Kooi EJ, Geurts JJ, Baas F, Lassmann H, Ramaglia V. Michailidou I, et al. Glia. 2017 Feb;65(2):264-277. doi: 10.1002/glia.23090. Epub 2016 Oct 25. Glia. 2017. PMID: 27778395 Free PMC article. - S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.
Nath N, Morinaga O, Singh I. Nath N, et al. J Neuroimmune Pharmacol. 2010 Jun;5(2):240-51. doi: 10.1007/s11481-009-9187-x. Epub 2010 Jan 21. J Neuroimmune Pharmacol. 2010. PMID: 20091246 Free PMC article. - Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury.
Galvan MD, Luchetti S, Burgos AM, Nguyen HX, Hooshmand MJ, Hamers FP, Anderson AJ. Galvan MD, et al. J Neurosci. 2008 Dec 17;28(51):13876-88. doi: 10.1523/JNEUROSCI.2823-08.2008. J Neurosci. 2008. PMID: 19091977 Free PMC article.